Aura+
Particle Characterization For All Biotherapeutics
Fully configured to support applications across protein, antibody, cell, and gene therapy workflows, Aura+ brings particle characterization to earlier stages of therapeutic development, so you can make better decisions sooner.
Particle Identification
5 µL to 10 mL Volume
1 Minute Per Sample
High Magnification Imaging
Why Choose Aura+?
When you need the flexibility to conduct particle characterization analyses on different types of biologics, including protein and antibody therapeutics, cell therapies, and gene therapies, the Aura+ has got you covered.
Powered by the Backgrounded Membrane Imaging (BMI) and Fluorescence Membrane Microscopy (FMM) technology shared within Aura family instruments, Aura+ enables applications from late discovery to development and manufacturing, enhancing decision-making and accelerating your success.
Analyze small volumes. The minimum sample volume is just 5 µL, enabling particle characterization earlier in the development timeline when sample volumes can be limited.
Learn more with innovative technology. Aura+ pairs BMI with FMM to deliver rich information on the number, size, and morphology of particles. You can even see translucent subvisible particles that other methods often miss.
Gain insight quickly. With a 96-well membrane plate and the ability to analyze one sample every minute, the Aura+ takes you from labeled samples to data in as little as 90 minutes.
See Clearer With High Magnification
With the high magnification capabilities of the Aura+, you can see more morphological detail of unlabeled particles, enabling decisive discrimination between your lead and undesirable particles.
Quickly differentiate and enumerate cells versus Dynabeads, quantify polysorbate degradation, and more.
